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Purpose: To investigate material density, ﬂow, and viscosity effects on microsphere distribution within an in vitro model
designed to simulate hepatic arteries.
Materials and Methods: A vascular ﬂow model was used to compare distribution of glass and resin surrogates in a clinically
derived ﬂow range (60–120 mL/min). Blood-mimicking ﬂuid (BMF) composed of glycerol and water (20%–50% vol/vol) was
used to simulate a range of blood viscosities. Microsphere distribution was quantiﬁed gravimetrically, and injectate solution was
dyed to enable quantiﬁcation by UV spectrophotometry. Microsphere injection rate (5–30 mL/min) and the inﬂuence of contrast
agent dilution of injection solution (0%–60% vol/vol) were also investigated.
Results: No signiﬁcant differences in behavior were observed between the glass and resin surrogate materials under any tested
ﬂow conditions (P ¼ .182; n ¼ 144 injections). Microspheres tend to align more consistently with the saline injection solution
(r2 ¼ 0.5712; n ¼ 144) compared with total BMF ﬂow distribution (r2 ¼ 0.0104; n ¼ 144). The most predictable injectate
distribution (ie, greatest alignment with BMF ﬂow, o 5% variation) was demonstrated with 4 10-mL/min injection rates of
pure saline solution, although o 20% variation with glass microsphere distribution was observed with injection solution
containing as much as 30% contrast medium when injected at 4 20 mL/min.
Conclusions: Glass and resin yttrium-90 surrogates demonstrated similar distribution in a range of clinically relevant ﬂow
conditions, suggesting that microsphere density does not have a signiﬁcant inﬂuence on microsphere distribution. Injection
parameters that enhanced the mixing of the spheres with the BMF resulted in the most predictable distribution.
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Volume 28 ’ Number 2 ’ February ’ 2017 261technical considerations, including delivery technique
and material (5). There are currently two commercially
available microsphere products composed of resin (SIR-
Spheres; Sirtex, North Sydney, Australia) and glass
(TheraSphere; Biocompatibles UK, Farnham, United
Kingdom), both of which comprise microspheres of
similar size, but with different densities (resin, 1.6 g/cm3;
glass, 3.3 g/cm3) (5–7). The difference in density has the
potential to affect in vivo localization, although studies
have shown no clinically relevant variation between
anterior and posterior distribution of both material types
(5,8). Uncertainty remains in regard to the mixing of the
injected particles with the blood and their eventual
distribution (2,9,10). The ability to predict microsphere
distribution based on density and injection technique
could enable enhanced dosimetry and ultimately treat-
ment success (11,12).
The radiation dose from 90Y microspheres is limited in
range, with 50% of the absorbed dose within 2.5 mm of
the microsphere (2). This necessitates ﬁnal positioning of
the microspheres close to their intended target and high-
lights the need for predicable distribution for maximum
effect. Radioembolization is often administered in a
proximal or lobar location, and it is an oversimpli-
ﬁcation to assume that the microspheres will mix homo-
geneously with the blood and then simply go wherever
the blood goes, although this is often presented in ﬂow-
distribution studies (13,14). Factors thought to be signi-
ﬁcant for the prediction of distribution of microspheres
include the size and density of the particles and the
degree to which the particles will homogeneously mix
with the blood during administration. When combinedFigure 1. Comparison of (a) typical hepatic vasculature showing the
(angiogram adapted with permission from Kerlan [15]) and (b) VFM
diameters labeled.with technologies such as dynamic computed tomography
(CT) for imaging of vascular ﬂow to allow an admin-
istration tailored to the patient’s hemodynamic charac-
teristics (2), there is potential to improve dosimetric
control.
The objective of the present study was to investigate
material density, ﬂow, and viscosity effects and their
inﬂuence on microsphere distribution within an in vitro
vascular ﬂow model (VFM) designed to simulate ﬂow
conditions within hepatic arteries. The central hypothesis
is that radioembolic surrogate density will affect ﬂow
distribution.MATERIALS AND METHODS
Experimental Setup
The VFM used for the present study was a silicone
vascular cast (Elastrat Sarl, Geneva, Switzerland) with
circular channel cross-sections, a 4-mm inlet, and six 0.9-
mm outlets (Fig 1) (15). The inlet diameter was chosen to
represent the hepatic vasculature at a typical injection
point for 90Y microsphere therapy at the right hepatic
artery (RHA), and the outlet diameter is akin to that of
a ﬁrst-order hepatic bifurcation (16,17).
The VFM was oriented in the vertical plane (ie, perpen-
dicular to the bench) to test density/gravitational inﬂuence
on distribution and in the horizontal plane to evaluate the
injection mixing. Inlet length was selected to ensure a fully
developed ﬂow proﬁle from the catheter injection point
before the ﬁrst bifurcation (calculation presented in
Appendix A [available online at www.jvir.org]) (6,7,18–27).RHA (RH) and the main arteries feeding liver segments V–VIII
vessel orientation with anterior, posterior, and internal channel
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Injection Rate
Microsphere surrogates in saline solution were intro-
duced via a 2.7-F, 110-cm Progreat microcatheter with a
straight tip (Terumo, Tokyo, Japan) into the VFM inlet
while blood-mimicking ﬂuid (BMF) was circulating
through the system (Fig 2). The catheter tip was
radially centered and aligned with the axis of the
channel, with its orientation visually conﬁrmed before
each injection to ensure repeatability. Catheter tip
orientation was found to have a profound effect on
microsphere distribution in previous simulations and
in vitro studies (18–20). Injection rate was controlled
with a PHD ULTRA syringe pump (Harvard Apparatus
UK, Cambridge, United Kingdom).
To evaluate the inﬂuence of microsphere density, the
injection rate was ﬁxed at 20 mL/min in accordance with
the package-insert instructions for use for glass micro-
spheres (TheraSphere Yttrium-90 Glass Microspheres
[package insert]. Farnham, UK: Biocompatibles UK
Ltd: 2016.). This condition was selected instead of the
less prescriptive resin injection methods consisting of
“puff-like or pulsed injections” (SIR - Spheres micro-
spheres [Yttrium-90 Microspheres] [package insert].
North Sydney, Australia: SirTex Medical: 2014.), as
pulsed injection would have introduced additional var-
iation to the results. To evaluate the effect of injection
solution ﬂow rate on mixing, constant injections were
analyzed at 5-, 10-, 20-, and 30-mL/min rates (Table).
These values cover the range of injection rates from the
lowest recorded resin injection rate (5 mL/min) to the
injection rate from the glass microsphere instructions for
use (20 mL/min) (TheraSphere Yttrium-90 Glass
Microspheres [package insert]).
Two nonradioactive microsphere surrogates were tested:
resin microspheres (Aminex W50, Bio-Rad, Hercules,
California; mean size, 32 mm; density, 1.6 g/mL) (6) and
glass microspheres (mean size, 25 mm; density, 3.3 g/mL;
BTG) (5,7). V-bottom vials were prepared with aFigure 2. Schematic of experimental setup with device orientation nstandardized (settled) volume of microspheres per vial to
remove volume-associated bias.
BMF Viscosity
BMF properties were selected to reproduce the kine-
matic viscosity of blood (28), in recognition that the
viscosity of (non-Newtonian) blood will vary in vivo
with blood pressure, ranging from 3.32 to 9.20 cP
(18,29–31), and that viscosity is a key property affecting
mixing and ﬂow behavior. For the surrogate material
density study, the BMF comprised a 44%:56% vol/vol
glycerol:water mixture modiﬁed with 15% sodium iodide
(28), yielding a dynamic viscosity of 4.51 cP (AMVn2-
PA automated microviscometer, 1.8-mm capillary;
Anton Paar, Ostﬁldern-Scharnhausen, Germany). For
the investigation of the viscosity effect on mixing
(Table), BMF with 20% vol/vol, 30% vol/vol, and 50%
vol/vol glycerol dilutions were tested, yielding measured
BMF viscosities of 3.03, 4.00, and 9.89 cP, respectively.
This was intended to test the ﬂow behavior over a range
of in vivo conditions while using a Newtonian ﬂuid.
BMF Flow Rate
The BMF was circulated through the inlet tubing and
VFM with a DOSE IT P910 peristaltic pump unit
(INTEGRA Biosciences, Zizers, Switzerland) at a nom-
inal rate of 120 mL/min, chosen to approximate RHA
ﬂow at the lower end of reported ranges (120–559 mL/
min) (18,31,32). Appendix A (available online at www.jvir.
org) includes details of the measured pump pressure trace
(Fig E1 [available online at www.jvir.org]). BMF ﬂow rate
of 60 mL/min, intended to represent that in a sedated
patient with low cardiac output, was also used to assess
whether a lower BMF ﬂow rate would accentuate the
effects of particle density (21).
The injection solution was 0.9% saline solution (Frese-
nius Kabi, Oberursel, Germany) dyed with 10 mg/mL
vol/vol Safranin O dye (S2255-25G; Sigma Aldrich UK,
Dorset, United Kingdom). The dye allowed visual assess-ot detailed.
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distribution (Cary Bio50 UV/Vis Spectrophotometer; Var-
ian, Santa Clara, California) at the outlets. For the
investigation of the viscosity effect on mixing, saline
solution with 0%–60% vol/vol contrast agent (Omnipaque
350 Iohexol; GE Healthcare, Little Chalfont, United
Kingdom) was used as the injection solution (Table).
Measured Outcome and Deﬁnitions
Replicates (n ¼ 3) of each ﬂow condition and surrogate
type were performed. During each test, the efﬂuent from
each outlet was collected and the volume was measured
as an indicator of ﬂow direction. Each sample was
diluted with BMF to an equal volume, and the dye
concentration was measured by UV spectroscopy. The
collected microspheres were then extracted, centrifuged,Figure 3. High-speed video still frames showing (a) developed ﬂow p
vessels and (b) showing uniform mixing at primary bifurcation injected
shows 3 magniﬁcation of the primary bifurcation in the outlined are
Table . Test Plan for Investigation
Objective Description
Microsphere density
and gravitational
effects
Vertical vs horizontal ﬂow inﬂuence on
microsphere distribution
Relative injection ﬂow
rate
Effect of modifying BMF ﬂow rate and injec
rate on microsphere distributions
Injection solution
viscosity
Effect of altered BMF viscosity and modiﬁca
of injection solution with 0%–60% vol/vol
contrast agent
BMF = blood-mimicking ﬂuid.and weighed for comparison by channel output with an
analytical balance (MSA324s-1CE-DI; Sartorius, Göt-
tingen, Germany). High-speed video was used qualita-
tively for ﬂow-distribution monitoring (Fig 3).
Microsphere “alignment” is deﬁned as the microsphere
weight percentage divided by the percentage BMF ﬂow
volume. Statistical comparison was made between
surrogate materials by Student t test (two-sided, 95%
conﬁdence).RESULTS
Effect of VFM Orientation
Glass and resin surrogates and injection dye were not
signiﬁcantly different between the vertical and horizontal
orientations (20.05% vs 24.19% [P ¼ .0999] and 17.21% vsroﬁle for 5-mL/min injection with saline solution favoring lower
with saline solution at 20 mL/min. (Scale is in centimeters; inset
a.)
Test Setup Outputs
Horizontal and vertical
orientation, standard 120 mL/
min ﬂow rate and 20 mL/min
injection rate, n ¼ 3 replicates
Average dye, surrogate
weight, and volume
ﬂow per channel
tion Horizontal orientation with
varied injection rate and ﬂow
rate, n ¼ 3 replicates
tion Horizontal orientation, standard
120 mL/min ﬂow rate,
standard 20 mL/min injection
rate, modiﬁed BMF and
injection viscosity, n ¼ 3
replicates
Figure 4. Anterior VFM channel dye, surrogate mass, and total
ﬂuid volume distribution by orientation (vertical and horizontal).
Average percentage for 12 replicate injections of resin and glass
surrogates with standard deviation is shown. Fluid volume
presented the only statistically signiﬁcant variation.
Figure 5. Anterior VFM channel distribution by surrogate
material for weight, dye, and volume percentages, with an
average of n ¼ 18 with standard deviation shown. Testing
performed in vertical VFM orientation shows no signiﬁcant
variation based on any parameter when comparing surrogate
properties.
Caine et al ’ JVIR264 ’ Flow Dynamics and Density Effects on 90Y Microsphere Distribution21.25% [P ¼ .0622], n ¼ 12; Fig 4). However, it was found
that the total ﬂow volume did distribute differently
(18.83% vs 13.05%; P o .05; n ¼ 12), with more total
ﬂow going to posterior vessels than anterior vessels.Effect of Microsphere Density on
Gravitational Sedimentation
A comparison of the resin and glass microsphere
distributions in the vertical VFM orientation (to empha-
size the inﬂuence of gravity; injection rate, 20 mL/min;
BMF ﬂow rate, 120 mL/min) demonstrated no signiﬁcant
difference between the materials as measured by dye
concentration (25.89% vs 28.15%; P ¼ .574; n ¼ 12),
microsphere weight (19.81% vs 24.26%; P ¼ .182; n ¼
12), and total ﬂuid volume (10.48% vs 14.44%; P ¼
0.213; n ¼ 12; Fig 5).
Reducing the injection rate to 10 mL/min and BMF
ﬂow rate to 60 mL/min yielded no signiﬁcant difference
in distribution between the resin and glass microspheres
in vertical VFM testing (19.81% vs 24.26%; P ¼ .182;
n ¼ 18; P 4 .05 by material type per channel).Correlation of Particle to Fluid Distribution
A moderate correlation between the distribution of
microspheres as measured by weight and distribution
of injection ﬂuid containing dye was obtained (r2 ¼
0.5712; n ¼ 144 combined glass and resin injections), but
the correlation of microsphere distribution with total
ﬂuid volume (BMF plus injection mixture) was poor
(r2 ¼ 0.0104; n ¼ 144 combined glass and resin
injections; Fig 6).Effect of Injection Solution Viscosity on
Distribution (Glass Only)
The effect of increasing the viscosity of the injection
solution by adding contrast agent from 0% to 60% vol/
vol showed generally reduced alignment of glass micro-
spheres to total ﬂuid volume for concentrations greater
than 30% vol/vol. As shown in Figure 7, the relative
alignment is closest to the optimum (ie, 100% alignment
of spheres and total ﬂuid volume) at or below
approximately 30% contrast medium in saline solution
for a ﬁxed injection ﬂow rate of 20 mL/min.
Effect of Injection Solution Flow Rate on
Distribution (Dye Only)
Dye-containing injection solution was introduced via the
microcatheter at constant ﬂow rates of 5–30 mL/min
into the pulsing BMF ﬂow (viscosity, 4 cP) with three
injection solution compositions (0%, 30%, and 60% vol/
vol contrast agent in saline solution). Dye distribution
was used as a surrogate for microsphere distribution,
having shown a representative correlation in previous
testing. Results indicated that, as the ﬂow rate of the
injection solution increased, there was better alignment
of injectate distribution relative to the total ﬂuid distri-
bution, approaching unity (Fig 8). For injection of saline
solution (viscosity, 1 cP), the distribution appeared
optimal at greater than 10 mL/min.DISCUSSION
The present study aimed to mimic aspects of hepatic
ﬂow during 90Y microsphere therapy, assessing the
effects of gravity on microsphere density and bulk ﬂow,
injection solution viscosity, and injection ﬂow rate on
Figure 6. Fit plot for microsphere mass versus dye concentration (a) and total ﬂuid volume (b) (n ¼ 144 combined injection results with
conﬁdence interval shown). Moderate correlation was demonstrated in comparing injection dye and mass (r2 ¼ 0.5712), but a poor
correlation was seen between microsphere mass and total ﬂuid volume (r2 ¼ 0.0104), indicating that dye concentration (injectate phase)
is an enhanced indicator of microsphere distribution.
Figure 7. Concentration of glass microspheres (percent per
channel divided by total ﬂow percentage) in anterior and poster-
ior channels versus contrast agent dilution. Injection was
performed at 20 mL/min into 120 mL/min BMF ﬂow. Hashed
ellipse identiﬁes favorable microsphere concentration indicative
of enhanced microsphere load delivered in the ﬂow direction.
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understanding and control of injection parameters could
potentially yield more predictable microsphere distribu-
tion and improved patient outcomes.
Observations with the VFM in vertical and horizontal
orientations showed that the resin and glass micro-
spheres had substantially equivalent distribution
(Figs 4, 5). Gravitational sedimentation was not observed
with either surrogate material. There was a gravitational
effect on the total volume ﬂow from each channel with
the VFM in the vertical orientation, with increased BMF
ﬂowing to the posterior channels. This ﬁnding correlates
with studies performed in vivo on posture-related blood
distribution (33,34).
Reducing the BMF ﬂow rate to 60 mL/min, intended
to test gravitational effects, consistently showed equiv-
alent microsphere distributions for glass and resin. Thisﬁnding aligns with previous work (8), and serves to
highlight the minimal inﬂuence of microsphere density
even in reduced ﬂow conditions.
Sedimentation theory explains the lack of gravita-
tional effect under the tested conditions. The critical
sedimentation velocity can be calculated for a micro-
sphere of a known density and size relative to the bulk
ﬂuid properties (21). The critical sedimentation velocities
for the glass and resin microspheres in BMF are 0.16
mm/s and 0.045 mm/s, respectively, far lower than the
BMF ﬂow rate of 79–159 mm/s (60–120 mL/min) under
test conditions. Therefore, the effect of microsphere
density on distribution is trivial in this model, in which
the ﬂow behavior is dominated by the BMF viscosity,
ﬂow rate, and channel geometry. The density of the
microsphere may become more important when the
blood ﬂow becomes signiﬁcantly reduced, as when
approaching stasis. This would be more relevant for
resin spheres because of the minimally embolic nature of
glass microsphere treatment (11).
Many studies have evaluated the factors affecting
microsphere distribution by using computational ﬂuid
dynamics simulations (6,10,19,20,35). Basciano et al (18)
showed that microparticles injected into a computational
ﬂuid dynamics–simulated vasculature would tend to
follow a “ﬂow stream” within the blood vessels. Treat-
ment of diffuse, hypervascular hepatocellular carcinoma
lesions requires sufﬁcient mixing of microspheres, as
microspheres following a single-directional ﬂow stream
could result in nonuniform radiation dose. Recently,
Jernigan et al (36) studied the propagation of resin and
glass microspheres in a two-dimensional in vitro “river
delta” model that suggested that resin microspheres
penetrated further while also demonstrating no inﬂuence
of gravity, leaving some questions as to the deﬁning
forces affecting microsphere distribution (eg, viscous
drag, density, and injection rate). In contrast, Basciano
Figure 8. Concentration percentage of dye in anterior (solid)
and posterior (outline) channels divided by the total ﬂow volume
percentage per channel versus injection ﬂow rate (n ¼ 2
replicates at each condition), with a target of 100% optimal ﬂow
alignment (dashed line). Separate graphs indicate contrast agent
concentrations in injection solution: 0% vol/vol (a), 30% vol/vol
(b), and 60% vol/vol (c).
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between ﬂuid and microsphere density is required to
inﬂuence microsphere sedimentation.
Microsphere distribution correlated poorly with total
ﬂuid volume; rather, the data suggest that distribution isbetter predicted by the dyed injection solution. This is
contrary to the conclusion of some studies that showed
injected microspheres fully correlating with the total
blood ﬂow, with microsphere distribution assessed by
90Y positron emission tomography/CT imaging
(8,13,14). Other studies would seem to agree with the
present ﬁndings, such as recent computer simulations
(6,10,19) that showed injection and bulk ﬂow rates to be
critical factors affecting distribution of microspheres. It
seems reasonable that the degree of mixing of the
injection solution and BMF will ultimately determine
the homogeneity of the microsphere distribution.
The present study examined whether modifying the
viscosity of the injection solution to more closely match
the viscosity of the BMF would result in enhanced
mixing of the two ﬂuids (22), resulting in increased
alignment with the bulk ﬂow. Tests showed a less
promising effect whereby contrast medium concen-
trations greater than 30% vol/vol produced diminishing
levels of microsphere mixing with the BMF. This
observation correlates with those of another in vivo
blood ﬂow study (30) in which 4 30% vol/vol contrast
medium dilution resulted in increased shear-associated
erythrocyte aggregation in microvascular blood ﬂow.
Increasing the viscosity of the injection solution, partic-
ularly with a higher-viscosity BMF, may cause the
mixing process to be inhibited and yield incomplete
mixing. Considering two-phase viscous ﬂow, a solution
of increasing viscosity will move more slowly and limit
the diffusion capabilities of particles contained within
that ﬂuid (22). Contrast medium concentrations as high
as 30% vol/vol may yield satisfactory mixing, and may
have some utility in visualizing the ﬂow with angio-
graphic imaging techniques. Recent studies (37) used
up to 50% vol/vol dilution of Isovue (Bracco, Milan,
Italy) during resin delivery, although the ionic strength
of the contrast agent was unreported (potential range of
3.3–20.9 cP viscosity). The viscosity of the 50% Isovue is
similar to the viscosity of the 0%–30% vol/vol
Omnipaque range presented for the present study, with
encouragingly similar results. However, it must be noted
that, in the present study, the pure saline solution in-
jection yielded the greatest microsphere alignment with
bulk ﬂow under the tested range of injection conditions.
Injection ﬂow rate is understood to be important to
solution mixing (6,10,19). In the present study, the use of
an injection ﬂow rate of greater than 10 mL/min was
shown to yield substantial alignment with the bulk ﬂow
in a range of BMF conditions when saline solution was
the injection solution. Increasingly viscous contrast
agent mixtures required a greater injection ﬂow rate to
achieve comparable levels of distribution. High-speed
video was used to observe the mechanics of mixing at the
VFM inlet and ﬁrst bifurcation and observe ﬂow streams
(Fig 3). At lower injection rates (5–10 mL/min) and a
BMF ﬂow rate of 120 mL/min, there was a clearly visible
laminar stream of injection solution providing evidence
Volume 28 ’ Number 2 ’ February ’ 2017 267of inadequate mixing (Fig E1 [available online at www.
jvir.org]). As the viscosity of the injection solution was
increased, higher injection ﬂow rates were required to
achieve satisfactory mixing. An explanation for the
importance of ﬂow is offered by jet mixing theory,
whereby the input ﬂow rate (at the catheter tip) must
overcome the bulk ﬂow inertia and viscous drag forces to
enable effective radial mixing (23,24).
The present study has several limitations. The ﬁrst is
that the VFM is not fully representative of the complex-
ities of a liver vascular network. The VFM is a scaled
two-dimensional representation of a ﬁrst-order hepatic
network (16) that is suitable for comparative results
between the outlet channels. The BMF viscosities
investigated included three points in a dynamic range
between 3.32 and 9.20 cP using a Newtonian ﬂuid BMF.
This is therefore a limited simulator of colloidal in vivo
blood ﬂow. The injection technique and administration
system were taken from the TheraSphere package insert.
The pulsed injection technique and administration
system for SIR-Spheres was not tested, and this is
observed as a limitation. Surrogate materials were
selected to represent the size and density of commercially
available radioembolic agents; however, nonradiolabeled
original products were not available for this study. It is
acknowledged that resin microspheres are administered
with water or dextrose 5% in water (SIR - Spheres
microspheres [Yttrium-90 Microspheres] [package
insert]; 38,39) and not saline solution, and that micro-
sphere injection volumes were standardized in this study
to avoid volume bias despite being observed to vary in
clinical practice, with resin treatments typically involving
10–40 million microspheres versus 1–8 million micro-
spheres for glass. The catheter tip was not mechanically
ﬁxed in position near its tip, even though efforts were
made to standardize the tip position and angle during
testing. Although it is likely that a concentration of as
much as 30% vol/vol contrast medium would be visible
with existing angiographic imaging techniques, concur-
rent contrast medium and microsphere injection is not
currently indicated for either microsphere product
(TheraSphere Yttrium-90 Glass Microspheres [package
insert], SIR - Spheres microspheres [Yttrium-90 Micro-
spheres] [package insert]).
The present study investigated several parameters
affecting microsphere distributions in an in vitro ﬂow
model mimicking radioembolic therapy to the liver. No
signiﬁcant difference in ﬂow distribution was observed in
terms of surrogate material density. It was observed that
injection solution distribution was a better predictor of
microsphere deposition than total ﬂuid volume. Injection
rates greater than 10 mL/min were found to enhance
mixing, aligning more closely to bulk ﬂuid ﬂow. Injec-
tions solutions could also be modiﬁed with as much as
30% vol/vol contrast agent for potential visualization of
the ﬂow with angiographic techniques; however, increas-
ing the concentration of contrast medium to more than30% vol/vol resulted in signiﬁcant loss of microsphere
ﬂow alignment.REFERENCES
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SUPPLEMENTARY METHODS
1: Pressure Proﬁle of Blood Mimicking
Fluid Pump And Calculated Pulsatility
(Womersley Number)
A human vasculature is subject to pulsing blood ﬂow,
with expected implications in mixing of the injection
solution (containing microspheres) with the blood. The
pulsatile motion of the blood-mimicking ﬂuid (BMF) in
the present study was intended to mimic mixing con-
ditions in a liver right hepatic artery. A pressure plot was
generated for the 4-mm inlet channel of the vascular ﬂow
model (VFM) using a research-grade blood pressure
transducer (220v; Harvard Apparatus UK, Cambridge,
United Kingdom), data-acquisition signal board (NI
USB-6009; National Instruments, Austin, Texas), and
custom MatLab acquisition code (MathWorks, Natick,
Massachusetts), as shown in Figure E1. The plot shown
is for BMF composed of a 44%:56% vol/vol glycerol:
water mixture modiﬁed with 15% sodium iodide with a
dynamic viscosity of 4.51 cP, with BMF nominally
circulating at 120 mL/min.
The analysis of the inﬂuence of pulsatile ﬂow on
mixing uses a dimensionless value known as the
Womersley number (denoted α), a relative measure of
the mixing potential of injectate and blood (26). The
Womersley number is deﬁned by the following equation:
α ¼ L ωρ
η
 
1=2
Equation 1: Equation for Womersley number repre-
sentative of ﬂow pulsatility.
where L is the appropriate channel length scale, ω is the
angular frequency of a pulse waveform taken from aFigure E1. Pressure plot for inlet pulsatile pressure for calculation of a
pump cycle (right).pressure plot, ρ is ﬂuid density, and η is the kinematic
viscosity term.
This value can be applied to the pulsatile waveform to
analyze the inﬂuence of pulsatile mixing. The 4-mm-
diameter inlet channel of the VFM used here has an α of
2.2–3.9 with ω of 10.47 at a BMF viscosity range of
3.03–9.89 cP over a time period of 0.6 seconds. The
reported Womersley number for human vascular sys-
tems is between 0.04 in arterioles and 4.4 in the larger
carotid artery (25,26), and therefore the pulsatility of the
tested system is within the biologic range appropriate to
hepatic lobar vasculature.2: Catheter Tip Alignment
Previous work (17–19) has shown the importance of
catheter tip orientation relative to the “blood vessel” on
microsphere distribution. Effort was made to ensure that
the straight (end-hole) catheter tip was centered inside
the VFM inlet channel and aligned with the axis of the
ﬂow channel. In addition, the entrance length of the inlet
channel, measured from the tip of the catheter to the ﬁrst
bifurcation, was controlled to ensure that there would be
adequate opportunity for the injectate and microspheres
to completely mix with the BMF before reaching the ﬁrst
bifurcation. Entrance length required for fully developed
ﬂow in laminar conditions is deﬁned as follows (27):
Le=D¼0:6þ0:056Re
Equation 2: Entrance length equation for fully devel-
oped ﬂow proﬁle.
where Le is entrance length, D is channel diameter, and
Re is Reynolds number. For the VFM and BMF range
(Reynolds number, 37–226) under test, maximum
entrance length of 53 mm at maximum ﬂow rate 120
mL/min at Reynolds number 226. The catheter tipngular pulse frequency (ω; left) and waveform proﬁle for a single
Figure E2. Flow streams in the VFM inlet (20% glycerol BMF;
120 mL/min) with injection ﬂow rates of 5 mL/min (top), 10 mL/
min, 20 mL/min, and 30 mL/min (bottom) of injection solution
with dye (60% contrast medium). Images acquired at “systole”
phase of pump cycle during injection.
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the ﬁrst bifurcation.
3: Critical Sedimentation Velocity
An explanation for the equivalent ﬂow behavior of the
two microsphere materials (particles of similar size but
quite different densities) can be found in sedimentation
theory. The critical sedimentation velocity (vs in Eq. 3)
as a function of the microsphere and BMF density is
given by the following (25):
vs¼ 2g ρpρ
 
rp2
9m
Equation 3: Critical setting velocity equation for
spheres in ﬂuid ﬂow.
where g is the gravitational constant (9.81 m/s2), ρp is
the particle density (glass, 3.29 g/cm3 [8]; resin, 1.6 g/cm3
[9,10]), ρ is ﬂuid density (1.24 g/cm3, measured for BMF
composed of a 44%:56% vol/vol glycerol:water mixture
modiﬁed with 15% sodium iodide), rp is the mean
particle radius (glass, 25 mm [TheraSphere, Biocompat-
ibles UK, Farnham, United Kingdom]; resin average, 32
mm [SIR-Spheres; Sirtex, North Sydney, Australia]), and
m is the ﬂuid dynamic viscosity (0.0045 kg/m  s) as
measured by using an automated microviscometer
(AMVn2-PA, 1.8-mm capillary; Anton Paar, Ostﬁl-
dern-Scharnhausen, Germany]).
For glass spheres:
Glass vs¼ 2ð9:81Þ 33001240ð Þ25
2
9ð0:0045Þ ¼0:16 mm=s
For resin spheres:
Resin vs¼ 2ð9:81Þ 16001240ð Þ32
2
9ð0:0045Þ ¼0:045 mm=s
This calculation predicts a higher sedimentation rate
at lower ﬂuid velocities for the denser glass microspheres
purely as a function of material properties. The critical
sedimentation velocities for the glass and resin micro-
spheres in BMF are 0.16 mm/s and 0.045 mm/s,
respectively, far lower than the BMF velocity of 79–
159 mm/s (60–120 mL/min) under test. This would
suggest that settling will not be a dominant force to
determine distribution within the VFM.
4: Two-Phase Viscous Flow Theory,
Mixing, And Relative Injection Flow Rate
One of the hypotheses of the present study was that, by
modifying the viscosity of the injection solution to more
closely match the viscosity of the BMF, that advective (ie,
turbulent) mixing of the ﬂuids would be enhanced and
could potentially be optimized. Another hypothesis was
that modifying the ﬂow rate of the injection solution couldbe optimized to enhance mixing. In testing, it was found
that increasing the injection solution viscosity yielded
reduced ﬂow miscibility, in that there was greater viscous
resistance to advective ﬂow mixing. In contrast, increasing
the injection ﬂow rate from the catheter appears to provide
increased advective mixing and particle dispersion
throughout the ﬂow channel. These effects are described
by jet mixing theory, whereby the input ﬂow velocity must
override the BMF bulk ﬂow ﬂuidic conditions (inertia/
viscosity) to enable effective mixing within the inlet
channel (32,33). Adding contrast medium to the injection
solution serves to increase the density and viscosity of the
injection solution, thereby slowing the relative velocity and
restricting the radial mixing in the entrance channel (30).
High-speed video of the inlet channel immediately
downstream of the catheter tip was used to visualize the
effects of injection velocity (Fig E2). With insufﬁcient
injection velocity, the injectate (colored with red
Safranin O dye) will follow a single ﬂow stream,
whereas increased velocity yields turbulent mixing of
the injectate with the BMF and increases mixing of
injection solution.
